| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 11 Feb 2025 | 4 Feb 2025 |
| BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Intimation for Board Meeting to be held to consider Unaudited Financial Results for the Quarter ended 31st December 2024 alongwith other routine businesses. Outcome of Board meeting held on 11.02.2025 (As per BSE Announcement Dated on 11/02/2025) | ||
| Board Meeting | 30 Dec 2024 | 30 Dec 2024 |
| Appointment of Mr. Meet Shah (DIN: 06578351) as additional director under the catagory of promoter non executive director of the company | ||
| Board Meeting | 14 Nov 2024 | 7 Nov 2024 |
| BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Intimation for meeting of Board of Directors scheduled to be held on Thursday 14th November 2024 to consider and approve un-audited Financial Results for the quarter as well as half year ended on 30th September 2024 and other routine businesses OUTCOME OF BOARD MEETING HELD ON 14TH NOVEMBER, 2024 PURSUANT TO REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (As per BSE Announcement dated on 14/11/2024) | ||
| Board Meeting | 13 Aug 2024 | 8 Aug 2024 |
| BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve Intimation for meeting of Board of the Directors to be held on Tuesday 13th August 2024 pursuant to the Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 Outcome of Board Meeting held on Tuesday 13th August, 2024 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As per BSE Announcement dated on 13/08/2024) | ||
| Board Meeting | 30 May 2024 | 22 May 2024 |
| BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve Audited Financial Results for the fourth Quarter as well as financial year ended on 31st March 2024 along with Auditors Report thereon and Other routine matters with the permission of the chair. With reference to the above captioned subject and pursuant to the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors of the Company in their meeting (Serial No. 01/2024-2025) held on today i.e., Thursday, 30th Day of May, 2024, has inter alia, considered and approved the Businesses as enclosed in the attachment. Read less.. Reappointment of Secretarial Auditor for F.Y. 2024-25. (As Per BSE Announcement Dated on 30.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
